Skip to main content

Table 2 Summary of reported cases of membranous nephropathy associated with Castleman’s disease

From: Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature

 

Article

Age

Sex

TP (g/dl)

Alb (g/dl)

Cr (mg/dl)

VEGF (pg/ml)

IL-6 (pg/ml)

CRP (mg/dl)

IgG (mg/dl)

Proteinuria (g/day)

1

Weisenburger 1979

51

M

6.8

0.8

1.3

NA

NA

NA

2960

10

2

Ruggieri 1990

15

F

5

2.1

NA

NA

NA

NA

300

20

3

Komaba 2008 pat 1

46

M

11

2

0.65

NA

23.8

8.8

6070

1

4

Tazi 2012

45

M

NA

1.9

0.69

NA

NA

12

NA

7.2

5

Xu 2012 pat 15

56

M

NA

2.28

NA

NA

NA

14.8

NA

NA

6

Sun 2020 pat 12

44

M

NA

NA

NA

89.2

NA

NA

NA

NA

7

Furutera 2020 pat 1

58

M

8.7

2.1

1.2

NA

36

8.6

4156

4.4 (g/gCr)

8

The present case

43

M

11.7

2.6

0.71

467

15.5

7.65

6940

1.43 (g/gCr)

  1. Alb Albumin, Cr Creatinine, CRP C-reactive protein, F Female, IgG Immunoglobulin G, IL-6 Interleukin-6, M Man, NA Not available, pat Patient, TP Total protein, VEGF Vascular endothelial growth factor